Want to see ANNX full AI Analyst Report?
Annexon Biosciences (ANNX) Stock Forecast & Price Target
1,428 Followers
ANNX Analyst Ratings
Strong Buy
6Buy1Hold0Sell
Based on 7 analysts giving stock ratings to Annexon Biosciences in the past 3 months
ANNX Stock 12 Month Forecast
Average Price Target
$17.16▲(309.47% Upside)Based on 7 Wall Street analysts offering 12 month price targets for Annexon Biosciences in the last 3 months. The average price target is $17.16 with a high forecast of $27.00 and a low forecast of $3.94. The average price target represents a 309.47% change from the last price of $4.19.
Past 12 Months12 Month ForecastJan2026Oct2026
High$27.00
Average$17.16
Low$3.94
Highest Price TargetHighest$27.00Average Price Target$17.16Lowest Price TargetLowest$3.94
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Ananda Ghosh | H.C. Wainwright | $25 | buy | 496.66%Upside | Reiterated | 11/04/26 | ||
| Phil Nadeau | TD Cowen | $3.94 | buy | -5.97%Downside | Reiterated | 11/04/26 | ||
| Tazeen Ahmad | Bank of America Securities | ― | buy | ― | Reiterated | 11/04/26 | ||
| Derek Archila | Wells Fargo | $27 | buy | 544.39%Upside | Reiterated | 10/30/26 | ||
| Anupam Rama | J.P. Morgan | $14→$15 | buy | 258.00%Upside | Assigned | 09/30/26 | ||
| Joseph Stringer | Needham | $25 | buy | 496.66%Upside | Reiterated | 08/12/26 | ||
| Salveen Richter | Goldman Sachs | $7 | hold | 67.06%Upside | Reiterated | 08/06/26 | ||
| Jonathan Wolleben | Citizens JMP | $3 | sell | -28.40%Downside | Initiated | 07/21/26 | ||
 Unknown AnalystNot Ranked | Raymond James | $7.85 | hold | 87.35%Upside | Initiated | 07/21/26 | ||
| William Maughan | Clear Street | $17 | buy | 305.73%Upside | Reiterated | 03/30/26 | ||
| Andrew Tsai | Jefferies | $10 | buy | 138.66%Upside | Reiterated | 11/11/25 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Ananda GhoshH.C. Wainwright | BuyReiterated$25 | 11/04/26 | 496.66%Upside | ||
| Phil NadeauTD Cowen | BuyReiterated$3.94 | 11/04/26 | -5.97%Downside | ||
| Tazeen AhmadBank of America Securities | BuyReiterated | 11/04/26 | ― | ||
| Derek ArchilaWells Fargo | BuyReiterated$27 | 10/30/26 | 544.39%Upside | ||
| Anupam RamaJ.P. Morgan | BuyAssigned$14→$15 | 09/30/26 | 258.00%Upside | ||
| Joseph StringerNeedham | BuyReiterated$25 | 08/12/26 | 496.66%Upside | ||
| Salveen RichterGoldman Sachs | HoldReiterated$7 | 08/06/26 | 67.06%Upside | ||
| Jonathan WollebenCitizens JMP | SellInitiated$3 | 07/21/26 | -28.40%Downside | ||
| Unknown AnalystRaymond JamesNot Ranked | HoldInitiated$7.85 | 07/21/26 | 87.35%Upside | ||
| William MaughanClear Street | BuyReiterated$17 | 03/30/26 | 305.73%Upside | ||
| Andrew TsaiJefferies | BuyReiterated$10 | 11/11/25 | 138.66%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Annexon Biosciences
3 Months
Success Rate11/20 ratings generated profit
55%
Average Return
+4.41%
Copying Derek Archila's trades and holding each position for 3 Months would result in 55.00% of your transactions generating a profit, with an average return of +4.41% per trade.
1 Year
Success Rate7/12 ratings generated profit
58%
Average Return
+35.94%
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +35.94% per trade.
2 Years
Success Rate6/12 ratings generated profit
50%
Average Return
+19.47%
Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +19.47% per trade.
ANNX Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 8 | 13 | 16 | 12 | 6 |
| Buy | 2 | 1 | 1 | 1 | 2 |
| Hold | 2 | 2 | 2 | 1 | 0 |
| Sell | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 13 | 17 | 20 | 14 | 8 |
In the current month, ANNX has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANNX average Analyst price target in the past 3 months is 17.16.
ANNX Financial Forecast
High$-0.25
Consensus$-0.28
Low$-0.30
ANNX Earnings Forecast
Next quarter’s earnings estimate for ANNX is -$0.28 with a range of -$0.30 to -$0.25. The previous quarter’s EPS was -$0.28. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$0.00
Consensus$0.00
Low$0.00
ANNX Sales Forecast
Next quarter’s sales forecast for ANNX is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ANNX Stock Forecast FAQ
What is ANNX’s average 12-month price target, according to analysts?
Based on analyst ratings, Annexon Biosciences’s 12-month average price target is $17.16.
What is ANNX’s upside potential, based on the analysts’ average price target?
Annexon Biosciences has 309.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ANNX a Buy, Sell or Hold?
Annexon Biosciences has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
What is Annexon Biosciences’s price target?
The average price target for Annexon Biosciences is $17.16. This is based on 7 12-month price targets, issued in the past 3 months. The highest analyst price target is $27.00, the lowest forecast is $3.94. The average price target represents a 309.47% increase from the current price of $4.19.
What do analysts say about Annexon Biosciences?
Annexon Biosciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of ANNX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
